Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Net Cash Flow (2020 - 2024)

RAPT Therapeutics' Net Cash Flow history spans 5 years, with the latest figure at $131.8 million for Q4 2024.

  • For Q4 2024, Net Cash Flow rose 2080.35% year-over-year to $131.8 million; the TTM value through Dec 2024 reached $122.3 million, up 1332.89%, while the annual FY2024 figure was $122.3 million, 1332.89% up from the prior year.
  • Net Cash Flow for Q4 2024 was $131.8 million at RAPT Therapeutics, up from $823000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $131.8 million in Q4 2024 and bottomed at -$62.6 million in Q2 2020.
  • The 5-year median for Net Cash Flow is $2.4 million (2023), against an average of $4.6 million.
  • The largest annual shift saw Net Cash Flow crashed 867.16% in 2021 before it soared 4337.88% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at $4.7 million in 2020, then plummeted by 867.16% to -$36.0 million in 2021, then skyrocketed by 131.25% to $11.2 million in 2022, then plummeted by 159.23% to -$6.7 million in 2023, then soared by 2080.35% to $131.8 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Net Cash Flow are $131.8 million (Q4 2024), $823000.0 (Q3 2024), and -$8.2 million (Q2 2024).